Alpelisib is an inhibitor of the PI3K signaling pathway, specifically designed for HR /HER2breast cancer patients with PIK3CA mutations. It comes in 3 strengths: 50 mg, 200 mg, and 300 mg. And they’re all these coated tablets.
The suggested amount to take each day is 300 mg, and you should have it with something to eat. Each pack holds 28 tablets, all in those blister things.
